Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


2 J Bone Miner Res
3 J Clin Endocrinol Metab
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    J Bone Miner Res

  1. FARR J, Rowsey J, Eckhardt B, Thicke B, et al
    Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans.
    J Bone Miner Res. 2019 Mar 26. doi: 10.1002/jbmr.3729.
    PubMed     Text format     Abstract available

  2. FERRARI S, Libanati C, Cjf L, Brown JP, et al
    Relationship Between Bone Mineral Density T-score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment.
    J Bone Miner Res. 2019 Mar 28. doi: 10.1002/jbmr.3722.
    PubMed     Text format     Abstract available

    J Clin Endocrinol Metab

  3. REID LJ, Muthukrishnan B, Patel D, Seckl JR, et al
    Predictors of nephrolithiasis, osteoporosis and mortality in primary hyperparathyroidism.
    J Clin Endocrinol Metab. 2019 Mar 27. pii: 5419224. doi: 10.1210/jc.2018-02483.
    PubMed     Text format     Abstract available

  4. BARRIONUEVO P, Gionfriddo MR, Castaneda-Guarderas A, Zeballos-Palacios C, et al
    Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review.
    J Clin Endocrinol Metab. 2019;104:1631-1636.
    PubMed     Text format     Abstract available

  5. EASTELL R, Rosen CJ, Black DM, Cheung AM, et al
    Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019;104:1595-1622.
    PubMed     Text format     Abstract available

    PLoS One

  6. HIROTA Y, Nakagawa K, Isomoto K, Sakaki T, et al
    Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.
    PLoS One. 2018;13:e0199856.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.